NO955067D0 - FVII/TF peptider - Google Patents

FVII/TF peptider

Info

Publication number
NO955067D0
NO955067D0 NO955067A NO955067A NO955067D0 NO 955067 D0 NO955067 D0 NO 955067D0 NO 955067 A NO955067 A NO 955067A NO 955067 A NO955067 A NO 955067A NO 955067 D0 NO955067 D0 NO 955067D0
Authority
NO
Norway
Prior art keywords
pct
date
sec
fvii
peptides
Prior art date
Application number
NO955067A
Other languages
English (en)
Other versions
NO955067L (no
Inventor
Ross W Stephens
Lars Orning
Kjell Steinar Sakariassen
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939312601A external-priority patent/GB9312601D0/en
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Publication of NO955067L publication Critical patent/NO955067L/no
Publication of NO955067D0 publication Critical patent/NO955067D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
NO955067A 1993-06-18 1995-12-14 FVII/TF peptider NO955067D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939312601A GB9312601D0 (en) 1993-06-18 1993-06-18 Peptides
GB9409335A GB9409335D0 (en) 1993-06-18 1994-05-10 Peptides
PCT/GB1994/001315 WO1995000541A1 (en) 1993-06-18 1994-06-17 Factor vii-derived peptides

Publications (2)

Publication Number Publication Date
NO955067L NO955067L (no) 1995-12-14
NO955067D0 true NO955067D0 (no) 1995-12-14

Family

ID=26303086

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955067A NO955067D0 (no) 1993-06-18 1995-12-14 FVII/TF peptider

Country Status (15)

Country Link
US (1) US5962418A (no)
EP (1) EP0703923B1 (no)
JP (1) JPH08511794A (no)
CN (1) CN1125450A (no)
AT (1) ATE171950T1 (no)
CA (1) CA2164422A1 (no)
CZ (1) CZ334095A3 (no)
DE (1) DE69413817T2 (no)
DK (1) DK0703923T3 (no)
FI (1) FI956055A (no)
HU (1) HUT74873A (no)
NO (1) NO955067D0 (no)
NZ (1) NZ267453A (no)
SK (1) SK156395A3 (no)
WO (1) WO1995000541A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
GB9425381D0 (en) * 1994-12-15 1995-02-15 Nycomed Pharma As Peptides
GB9425380D0 (en) * 1994-12-15 1995-02-15 Nycomed Pharma As Peptides
US5837684A (en) * 1995-06-07 1998-11-17 Nycomed Imaging As Peptides
WO1999013063A1 (en) * 1997-09-09 1999-03-18 Nycomed Imaging As Factor vii fragments and analogs thereof and their use in the treatment of blood clottng disorders
WO1999013062A1 (en) * 1997-09-09 1999-03-18 Nycomed Imaging As Factors vii fragments and analogs thereof and their use in the treatment of blood clotting disorders
EP0987274A1 (en) 1998-09-15 2000-03-22 Hoechst Marion Roussel Deutschland GmbH Factor VIIa Inhibitors
JP2003530819A (ja) 1999-06-14 2003-10-21 ノボ ノルディスク アクティーゼルスカブ ＦＶＩＩａ／ＴＦ活性阻害化合物
CA2373735A1 (en) 1999-07-02 2001-01-11 Genentech, Inc. Fviia antagonists
US7164002B2 (en) 2002-02-06 2007-01-16 Genentech, Inc. FVIIa antagonists
US20060257359A1 (en) * 2005-02-28 2006-11-16 Cedric Francois Modifying macrophage phenotype for treatment of disease
ES2856968T3 (es) 2016-01-15 2021-09-28 Rigshospitalet Adquisición de imágenes de TEP cuantitativas de la expresión de factor tisular usando factor VII inhibido en el punto activo y marcado con 18F
MA46864A (fr) 2016-11-17 2021-04-28 Minerva Imaging Aps Facteur vii inhibé par le site actif marqué par 177-lu

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496927A (en) * 1985-02-04 1996-03-05 Merrell Pharmaceuticals Inc. Peptidase inhibitors
DE3684633D1 (de) * 1985-04-16 1992-05-07 Suntory Ltd Dipeptid-derivate von fettsaeure, verfahren zu ihrer herstellung, heilmittel, das sie enthaelt und anwendung.
US5087564A (en) * 1985-06-20 1992-02-11 Monsanto Company Release of recombinant peptides from polypeptides using V8 endopeptidase
US5047401A (en) * 1985-09-09 1991-09-10 Board Of Regents, The University Of Texas System Use of dipeptide alkyl esters to treat GVHD
EP0391999A4 (en) * 1988-09-23 1991-03-13 Corvas, Inc. Peptidyl inhibitors of the initiation of coagulation
ATE180834T1 (de) * 1990-01-29 1999-06-15 Zymogenetics Inc Antikoagulierende proteine
DE4007902A1 (de) * 1990-03-13 1991-09-19 Behringwerke Ag Synthetische peptide, die sequenzen aus faktor viia enthalten und deren verwendung
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
WO1993009804A1 (en) * 1991-11-18 1993-05-27 The Scripps Research Institute Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation

Also Published As

Publication number Publication date
AU6975594A (en) 1995-01-17
CN1125450A (zh) 1996-06-26
EP0703923A1 (en) 1996-04-03
NZ267453A (en) 1997-03-24
NO955067L (no) 1995-12-14
AU691814B2 (en) 1998-05-28
DE69413817D1 (de) 1998-11-12
FI956055A (fi) 1996-01-26
JPH08511794A (ja) 1996-12-10
US5962418A (en) 1999-10-05
WO1995000541A1 (en) 1995-01-05
SK156395A3 (en) 1996-06-05
FI956055A0 (fi) 1995-12-15
HUT74873A (en) 1997-02-28
CA2164422A1 (en) 1995-01-05
DE69413817T2 (de) 1999-06-10
DK0703923T3 (da) 1999-06-21
CZ334095A3 (en) 1996-07-17
EP0703923B1 (en) 1998-10-07
HU9503593D0 (en) 1996-02-28
ATE171950T1 (de) 1998-10-15

Similar Documents

Publication Publication Date Title
DK0535091T3 (da) Knogleinducerende farmaceutiske formuleringer
NO955067L (no) FVII/TF peptider
IL129238A0 (en) N-(aryl/heteroarylacetyl) amino acid esters pharmaceutical compositions comprising same and methods for inhibiting b-amyloid peptide release and/ or its synthesis by use of such compounds
BR9607647A (pt) Derivado de insulina e composição farmacêutica e processo para o tratamento de diabetes em um paciente em necessidade deste tratamento
SE0002202D0 (sv) New peptides
MY135057A (en) Dolastatin 15 derivatives
DE60335101D1 (de) Antimikrobielles polypeptid und nutzung davon
HUP0401441A2 (hu) Az 5-CNAC mint mellékpajzsmirigy hormon fragmentumok orális hordozószere
MXPA02000465A (es) Derivados ciclopeptidicos como inhibidores de la integrina alfav beta6.
SG129211A1 (en) Therapeutic molecules
KR910007960A (ko) 항응고성 펩티드
MX9606674A (es) Tratamiento de enfermedades humanas que involucran la desregulacion o disfuncion del sistema nervioso.
RU97112745A (ru) Варианты апротинина с улучшенными свойствами
DE69102069D1 (de) 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
GB9226144D0 (en) Further improvements relating to the radiolabelling of proteins
FI942938A0 (fi) Soijaproteiini tai -hydrolysaatit farmaseuttisissa koostumuksissa bioaktiivisten peptidien suojana entsymaattista inaktivoitumista vastaan
KR950704358A (ko) 카텝신 l 특이적 저해 폴리펩티드
DE69922150D1 (de) Deoxyhypusin reagenz und peptide
WO2000027374A3 (en) The use of excitatory amino acid transporter inhibitors to reduce cns white matter injury
IL117812A0 (en) N-substituted heterocyclic compounds their preparation and pharmaceutical compositions containing them
ECSP961741A (es) Insulina de caneda sencilla con alta bioactividad (

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application